Drug Profile
Etanercept biosimilar - Axxo
Latest Information Update: 17 Nov 2021
Price :
$50
*
At a glance
- Originator AXXO
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Disease-modifying antirheumatics; Recombinant fusion proteins; Skin disorder therapies
- Mechanism of Action Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Rheumatoid arthritis
Most Recent Events
- 17 Sep 2013 Investigation for Rheumatoid arthritis in Germany (Parenteral)